CONMED CORPORATION Restructuring Charges
CONMED CORPORATION (CNMD) reported Restructuring Charges of $3.20 million for the 3-month period ending 2020-06-30, per its 10-Q filed 2020-07-30.
Discontinued › Expense Statement › Operating Expenses
us-gaap:RestructuringCharges · last filed 2020-07-30
- CONMED CORPORATION restructuring charges for the quarter ending 2020-06-30 was $3.20M.
- CONMED CORPORATION restructuring charges for the quarter ending 2017-12-31 was $100.00K, a 97.84% decline year-over-year.
- CONMED CORPORATION restructuring charges for the quarter ending 2017-09-30 was $1.30M, a 260.11% increase year-over-year.
- CONMED CORPORATION restructuring charges for the quarter ending 2017-06-30 was $300.00K, a 72.22% decline year-over-year.
- CONMED CORPORATION restructuring charges for fiscal 2017 was $4.25M, a 56.35% decline from fiscal 2016.
- CONMED CORPORATION restructuring charges for fiscal 2016 was $9.74M, a 55.07% decline from fiscal 2015.
- CONMED CORPORATION restructuring charges for fiscal 2015 was $21.67M, a 0.74% increase from fiscal 2014.
- CONMED CORPORATION restructuring charges for fiscal 2014 was $21.51M, a 23.80% increase from fiscal 2013.
| Period end | Restructuring Charges 3 month | Restructuring Charges 3 month as first filed | Restructuring Charges 6 month | Restructuring Charges 6 month as first filed | Restructuring Charges 9 month | Restructuring Charges 9 month as first filed | Restructuring Charges 12 month | Restructuring Charges 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2020-06-30 | $3.20M 10-Q · filed 2020-07-30 | $3.20M 10-Q · filed 2020-07-30 | ||||||
| 2017-12-31 | $100.00K 10-K · filed 2019-02-25 | $1.40M derived: sum of 2 quarters · filed 2019-02-25 | $1.70M derived: sum of 3 quarters · filed 2019-02-25 | $4.25M 10-K · filed 2018-02-26 | ||||
| 2017-09-30 | $1.30M 10-K · filed 2019-02-25 | $1.60M derived: sum of 2 quarters · filed 2019-02-25 | $4.13M 10-Q · filed 2017-11-02 | $8.74M derived: sum of 4 quarters · filed 2019-02-25 | ||||
| 2017-06-30 | $300.00K 10-K · filed 2019-02-25 | $2.82M 10-Q · filed 2017-07-27 | $7.44M derived: sum of 3 quarters · filed 2019-02-25 | $7.80M derived: sum of 4 quarters · filed 2019-02-25 | ||||
| 2017-03-31 | $2.50M 10-K · filed 2019-02-25 | $2.52M 10-Q · filed 2017-04-27 | $7.14M derived: sum of 2 quarters · filed 2019-02-25 | $7.50M derived: sum of 3 quarters · filed 2019-02-25 | $8.58M derived: sum of 4 quarters · filed 2019-02-25 | |||
| 2016-12-31 | $4.64M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $5.00M derived: sum of 2 quarters · filed 2018-02-26 | $6.08M derived: sum of 3 quarters · filed 2018-02-26 | $9.74M 10-K · filed 2018-02-26 | $9.94M 10-K · filed 2017-02-27 | |||
| 2016-09-30 | $361.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | $1.44M derived: sum of 2 quarters · filed 2017-11-02 | $5.10M 10-Q · filed 2017-11-02 | $11.79M derived: sum of 4 quarters · filed 2018-02-26 | ||||
| 2016-06-30 | $1.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-27 | $4.74M 10-Q · filed 2017-07-27 | $11.43M derived: sum of 3 quarters · filed 2018-02-26 | $14.08M derived: sum of 4 quarters · filed 2018-02-26 | ||||
| 2016-03-31 | $3.65M 10-Q · filed 2017-04-27 | $10.35M derived: sum of 2 quarters · filed 2018-02-26 | $13.00M derived: sum of 3 quarters · filed 2018-02-26 | $16.82M derived: sum of 4 quarters · filed 2018-02-26 | ||||
| 2015-12-31 | $6.70M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $9.34M derived: sum of 2 quarters · filed 2018-02-26 | $13.16M derived: sum of 3 quarters · filed 2018-02-26 | $21.67M 10-K · filed 2018-02-26 | ||||
| 2015-09-30 | $2.65M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-28 | $6.46M derived: sum of 2 quarters · filed 2016-10-28 | $14.97M 10-Q · filed 2016-10-28 | $4.45M 10-Q · filed 2015-10-23 | $32.53M derived: sum of 4 quarters · filed 2017-02-27 | |||
| 2015-06-30 | $3.82M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-28 | $12.33M 10-Q · filed 2016-07-28 | $3.98M 10-Q · filed 2015-07-27 | $29.88M derived: sum of 3 quarters · filed 2017-02-27 | $32.82M derived: sum of 4 quarters · filed 2017-02-27 | |||
| 2015-03-31 | $8.51M 10-Q · filed 2016-05-02 | $2.79M 10-Q · filed 2015-04-24 | $26.06M derived: sum of 2 quarters · filed 2017-02-27 | $29.00M derived: sum of 3 quarters · filed 2017-02-27 | $29.66M derived: sum of 4 quarters · filed 2017-02-27 | |||
| 2014-12-31 | $17.55M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | $20.50M derived: sum of 2 quarters · filed 2017-02-27 | $21.15M derived: sum of 3 quarters · filed 2017-02-27 | $21.51M 10-K · filed 2017-02-27 | $7.43M 10-K · filed 2015-02-23 | |||
| 2014-09-30 | $2.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-24 | $3.60M derived: sum of 2 quarters · filed 2014-10-24 | $3.96M 10-Q · filed 2014-10-24 | $18.37M derived: sum of 4 quarters · filed 2016-02-23 | ||||
| 2014-06-30 | $651.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-25 | $1.02M 10-Q · filed 2014-07-25 | $15.43M derived: sum of 3 quarters · filed 2016-02-23 | $16.27M derived: sum of 4 quarters · filed 2016-02-23 | ||||
| 2014-03-31 | $365.00K 10-Q · filed 2014-04-25 | $14.78M derived: sum of 2 quarters · filed 2016-02-23 | $15.62M derived: sum of 3 quarters · filed 2016-02-23 | $16.71M derived: sum of 4 quarters · filed 2016-02-23 | ||||
| 2013-12-31 | $14.41M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-23 | $15.25M derived: sum of 2 quarters · filed 2016-02-23 | $16.34M derived: sum of 3 quarters · filed 2016-02-23 | $17.38M 10-K · filed 2016-02-23 | $3.90M 10-K · filed 2014-02-24 | |||
| 2013-09-30 | $839.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-28 | $1.93M derived: sum of 2 quarters · filed 2013-10-28 | $2.96M 10-Q · filed 2013-10-28 | |||||
| 2013-06-30 | $1.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-29 | $2.13M 10-Q · filed 2013-07-29 | ||||||
| 2013-03-31 | $1.03M 10-Q · filed 2013-04-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B |